<DOC>
	<DOCNO>NCT02984696</DOCNO>
	<brief_summary>The aim study investigate effect 6 month oh HRT total anti-oxidant capacity , clinical , endocrine metabolic feature woman affect hypotalamic amenorrhea . The study group include 20 patient treat 1 mg transdermal estradiol daily 10mg oral Medroxyprogesterone acetate 16th 24th day therapy six month . Menstrual pattern , anthropometric parameter , hormonal assay , DXA bone metabolism parameter evaluate therapy .</brief_summary>
	<brief_title>Total Antioxidant Capacity Before After HRT Hypotalamic Amenorrhea</brief_title>
	<detailed_description />
	<mesh_term>Amenorrhea</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Hypotalamic Amenorrhea diabetes mellitus ( impaired glucose tolerance determine standard 75 gr oral glucose tolerance test ) hypertension significant liver renal impairment hormonal dysfunction ( hypothalamic , pituitary , PCOS , thiroidal adrenal ) neoplasm</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>